180 related articles for article (PubMed ID: 24078094)
21. Apolipoprotein A5 gene promoter region-1131T/C polymorphism is associated with risk of ischemic stroke and elevated triglyceride levels: a meta-analysis.
Pi Y; Zhang L; Yang Q; Li B; Guo L; Fang C; Gao C; Wang J; Xiang J; Li J
Cerebrovasc Dis; 2012; 33(6):558-65. PubMed ID: 22688093
[TBL] [Abstract][Full Text] [Related]
22. Association between Interleukin-1β Gene -511C>T/+3954C>T Polymorphisms and Aggressive Periodontitis Susceptibility: Evidence from a Meta-Analysis.
Hu YY; Liu JH; Jiang GB; Yuan RX; Niu YM; Shen M
Med Sci Monit; 2015 Jun; 21():1617-24. PubMed ID: 26038188
[TBL] [Abstract][Full Text] [Related]
23. The interleukin 10 -819C/T polymorphism and cancer risk: a HuGE review and meta-analysis of 73 studies including 15,942 cases and 22,336 controls.
Yu Z; Liu Q; Huang C; Wu M; Li G
OMICS; 2013 Apr; 17(4):200-14. PubMed ID: 23574339
[TBL] [Abstract][Full Text] [Related]
24. Association of single-nucleotide polymorphisms in the cell cycle genes with breast cancer in the British population.
Driver KE; Song H; Lesueur F; Ahmed S; Barbosa-Morais NL; Tyrer JP; Ponder BA; Easton DF; Pharoah PD; Dunning AM;
Carcinogenesis; 2008 Feb; 29(2):333-41. PubMed ID: 18174243
[TBL] [Abstract][Full Text] [Related]
25. Association between FAS 1377G>A polymorphism and breast cancer susceptibility: a meta-analysis.
Li K; Li W; Zou H; Zhao L
Tumour Biol; 2014 Jan; 35(1):351-6. PubMed ID: 23979975
[TBL] [Abstract][Full Text] [Related]
26. Significant association between CYP1A1 T3801C polymorphism and cervical neoplasia risk: a systematic review and meta-analysis.
Xia L; Gao J; Liu Y; Wu K
Tumour Biol; 2013 Feb; 34(1):223-30. PubMed ID: 23055196
[TBL] [Abstract][Full Text] [Related]
27. Vascular endothelial growth factor +936C/T polymorphism and breast cancer risk: a meta-analysis of 13 case-control studies.
Yan Y; Liang H; Li T; Guo S; Li M; Li S; Qin X
Tumour Biol; 2014 Mar; 35(3):2687-92. PubMed ID: 24390659
[TBL] [Abstract][Full Text] [Related]
28. CDKN1A and CDKN1B polymorphisms and risk of advanced prostate carcinoma.
Kibel AS; Suarez BK; Belani J; Oh J; Webster R; Brophy-Ebbers M; Guo C; Catalona WJ; Picus J; Goodfellow PJ
Cancer Res; 2003 May; 63(9):2033-6. PubMed ID: 12727815
[TBL] [Abstract][Full Text] [Related]
29. MTHFR C677T polymorphism associated with breast cancer susceptibility: a meta-analysis involving 15,260 cases and 20,411 controls.
Zhang J; Qiu LX; Wang ZH; Wu XH; Liu XJ; Wang BY; Hu XC
Breast Cancer Res Treat; 2010 Sep; 123(2):549-55. PubMed ID: 20143151
[TBL] [Abstract][Full Text] [Related]
30. Association between MDR1 C3435T polymorphism and risk of breast cancer.
Wang Z; Wang T; Bian J
Gene; 2013 Dec; 532(1):94-9. PubMed ID: 24070710
[TBL] [Abstract][Full Text] [Related]
31. Association of Polymorphisms in the Atrial Natriuretic Factor Gene with the Risk of Essential Hypertension: A Systematic Review and Meta-Analysis.
Wang J; Wang Z; Yu C
Int J Environ Res Public Health; 2016 Apr; 13(5):. PubMed ID: 27136577
[TBL] [Abstract][Full Text] [Related]
32. Genetic polymorphisms of CYP24A1 gene and cancer susceptibility: a meta-analysis including 40640 subjects.
Wang Y; Wang R; Yuan S; Liu X
World J Surg Oncol; 2023 Sep; 21(1):279. PubMed ID: 37670334
[TBL] [Abstract][Full Text] [Related]
33. Cumulative review and meta-analyses on the association between MTHFR rs1801133 polymorphism and breast cancer risk: a pooled analysis of 83 studies with 74,019 participants.
Zhang Y; Jia H; Wang S; Jiang D
Minerva Med; 2017 Feb; 108(1):57-73. PubMed ID: 27824246
[TBL] [Abstract][Full Text] [Related]
34. Association of TGF-β1 -509C/T polymorphisms with breast cancer risk: evidence from an updated meta-analysis.
Wang Y; Chu X; Meng X; Zou F
Tumour Biol; 2014 Feb; 35(2):935-42. PubMed ID: 23982878
[TBL] [Abstract][Full Text] [Related]
35. Five polymorphisms of vascular endothelial growth factor (VEGF) and risk of breast cancer: a meta-analysis involving 16,703 individuals.
Wang K; Liu L; Zhu ZM; Shao JH; Xin L
Cytokine; 2011 Nov; 56(2):167-73. PubMed ID: 21798757
[TBL] [Abstract][Full Text] [Related]
36. Impact of CYP1A1 Polymorphisms on Susceptibility to Chronic Obstructive Pulmonary Disease: A Meta-Analysis.
Wang CD; Chen N; Huang L; Wang JR; Chen ZY; Jiang YM; He YZ; Ji YL
Biomed Res Int; 2015; 2015():942958. PubMed ID: 26425562
[TBL] [Abstract][Full Text] [Related]
37. Association between MMP2-1306 C/T polymorphism and prostate cancer susceptibility: a meta-analysis based on 3906 subjects.
Zhang K; Chen X; Zhou J; Yang C; Zhang M; Chao M; Zhang L; Liang C
Oncotarget; 2017 Jul; 8(27):45020-45029. PubMed ID: 28445160
[TBL] [Abstract][Full Text] [Related]
38. Effects of common polymorphism rs11614913 in Hsa-miR-196a2 on lung cancer risk.
Yuan Z; Zeng X; Yang D; Wang W; Liu Z
PLoS One; 2013; 8(4):e61047. PubMed ID: 23593385
[TBL] [Abstract][Full Text] [Related]
39. Lupus Susceptibility Region Containing CDKN1B rs34330 Mechanistically Influences Expression and Function of Multiple Target Genes, Also Linked to Proliferation and Apoptosis.
Singh B; Maiti GP; Zhou X; Fazel-Najafabadi M; Bae SC; Sun C; Terao C; Okada Y; Heng Chua K; Kochi Y; Guthridge JM; Zhang H; Weirauch M; James JA; Harley JB; Varshney GK; Looger LL; Nath SK
Arthritis Rheumatol; 2021 Dec; 73(12):2303-2313. PubMed ID: 33982894
[TBL] [Abstract][Full Text] [Related]
40. APE1 Asp148Glu gene polymorphism and bladder cancer risk: a meta-analysis.
Liu C; Yin Q; Li L; Zhuang YZ; Zu X; Wang Y
Mol Biol Rep; 2013 Jan; 40(1):171-6. PubMed ID: 23143180
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
